Literature DB >> 19946891

Serum heme-albumin: an allosteric protein.

Paolo Ascenzi1, Mauro Fasano.   

Abstract

Heme scavenging by plasma proteins, including serum albumin (SA), provides protection against free-heme oxidative damage, limits access by pathogens to the heme, and contributes to iron homeostasis by recycling the heme iron. In turn, serum heme-albumin (SA-heme) acquires heme-based ligand-binding and (pseudo-)enzymatic properties. Heme binding to SA and SA-heme reactivity are allosterically and competitively modulated by endogenous and exogenous third components, this being relevant in pharmacotherapy management. (c) 2009 IUBMB

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946891     DOI: 10.1002/iub.263

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  19 in total

1.  Comparative proteomic analysis of the aging soleus and extensor digitorum longus rat muscles using TMT labeling and mass spectrometry.

Authors:  Daniela F S Chaves; Paulo C Carvalho; Diogo B Lima; Humberto Nicastro; Fábio M Lorenzeti; Mário Siqueira-Filho; Sandro M Hirabara; Paulo H M Alves; James J Moresco; John R Yates; Antonio H Lancha
Journal:  J Proteome Res       Date:  2013-09-25       Impact factor: 4.466

2.  Novel combinations of experimental and computational analysis tested on the binding of metalloprotoporphyrins to albumin.

Authors:  Jie Hu; Eduardo Hernandez Soraiz; Courtney N Johnson; Borries Demeler; Lorenzo Brancaleon
Journal:  Int J Biol Macromol       Date:  2019-05-10       Impact factor: 6.953

3.  Multi-wavelength analytical ultracentrifugation of human serum albumin complexed with porphyrin.

Authors:  Courtney N Johnson; Gary E Gorbet; Heidi Ramsower; Julio Urquidi; Lorenzo Brancaleon; Borries Demeler
Journal:  Eur Biophys J       Date:  2018-04-19       Impact factor: 1.733

4.  Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.

Authors:  Yu Cao; Francesco P Nicoletti; Giampiero De Sanctis; Alessio Bocedi; Chiara Ciaccio; Francesca Gullotta; Gabriella Fanali; Grazia R Tundo; Alessandra di Masi; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  J Biol Inorg Chem       Date:  2011-09-06       Impact factor: 3.358

5.  Evolution of the SOUL Heme-Binding Protein Superfamily Across Eukarya.

Authors:  Antonio Emidio Fortunato; Paolo Sordino; Nikos Andreakis
Journal:  J Mol Evol       Date:  2016-05-21       Impact factor: 2.395

6.  Warfarin modulates the nitrite reductase activity of ferrous human serum heme-albumin.

Authors:  Paolo Ascenzi; Grazia R Tundo; Gabriella Fanali; Massimo Coletta; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2013-09-15       Impact factor: 3.358

7.  Interaction of human serum albumin with novel 3,9-disubstituted perylenes.

Authors:  Mohammed J Farooqi; Mark A Penick; George R Negrete; Lorenzo Brancaleon
Journal:  Protein J       Date:  2013-08       Impact factor: 2.371

8.  The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.

Authors:  Carlo Meneghini; Loris Leboffe; Monica Bionducci; Gabriella Fanali; Massimiliano Meli; Giorgio Colombo; Mauro Fasano; Paolo Ascenzi; Settimio Mobilio
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

9.  Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin.

Authors:  Alessio Bocedi; Giampiero De Sanctis; Chiara Ciaccio; Grazia R Tundo; Alessandra Di Masi; Gabriella Fanali; Francesco P Nicoletti; Mauro Fasano; Giulietta Smulevich; Paolo Ascenzi; Massimo Coletta
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

10.  Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study.

Authors:  Xia Tao; Stephan Thijssen; Peter Kotanko; Chih-Hu Ho; Michael Henrie; Eric Stroup; Garry Handelman
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.